017180 — Myungmoon Pharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapValue Trap

Market Cap
KR₩57bn
Enterprise Value
KR₩153bn
Revenue
KR₩186bn

Annual balance sheet for Myungmoon Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Interim Report	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	7,318	7,097	5,264	8,064	4,558
Net Total Accounts Receivable
Net Total Receivables	35,659	30,345	34,700	38,928	42,190
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	80,577	67,466	70,707	81,436	80,329
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	149,944	142,861	141,777	140,196	161,994
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	243,025	223,263	230,450	236,549	257,988
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	125,320	113,088	110,821	116,373	92,660
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	155,824	143,006	140,928	153,096	161,137
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	87,201	80,257	89,522	83,453	96,851
Total Liabilities & Shareholders' Equity	243,025	223,263	230,450	236,549	257,988
Total Common Shares Outstanding